Gynecologic malignancies affect more than 83 000 women in the United States, each year. Because the disease involves the pelvis, many patients have side effects distal to this area in their lower extremities. The differential diagnosis of leg pain can be divided into vascular, neurologic, and musculoskeletal causes. In this review article, we address numerous etiologies of leg pain, reviewing the prevalence of disease, physical examination findings, diagnostic as well as treatment modalities.
MohlerER.Clinical features, diagnosis, and natural history of lower extremity peripheral artery disease. In: BasowDS eds. UpToDate. Waltham, MA; 2012.
3.
SelvinEErlingerTP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738–743.
4.
NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S6.
5.
McGeeSRBoykoEJ. Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med. 1998;158(12):1357–1364.
MartinoMAWilliamsonERajaramL. Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep vein thrombosis. Gynecol Oncol. 2007;106(3):439–445.
9.
SantosoJTEvansLLambrechtLWanJ. Deep venous thrombosis in gynecological oncology: incidence and clinical symptoms study. Eur J Obstet Gyn R B. 2009;144(2):173–176.
10.
IodiceSGandiniSLöhrMLowenfelsABMaisonneuveP. Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis. J Thromb Haemost. 2008;6(5):781–788.
11.
MorganMAIyengarTDNapiorkowskiBERubinSCMikutaJJ. The clinical course of deep vein thrombosis in patients with gynecologic cancer. Gynecol Oncol. 2002;84(1):67–71.
12.
TateoSMereuLSalamanoS. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol. 2005;99(1):119–125.
13.
MonrealMFernandez-LlamazaresJPandreuJUrrutiaASahuquilloJCContelE. Occult cancer in patients with venous thromboembolism: which patients, which cancers. Thromb Haemost. 1997;78(5):1316–1318.
14.
LandawSABauerKA.Approach to the diagnosis and therapy of lower extremity deep vein thrombosis. In: BasowDS, ed. UpToDate, Waltham, MA;2012.
15.
WhitworthJMSchneiderKEFredrickPJ. Double prophylaxis for deep venous thrombosis in patients with gynecologic oncology who are undergoing laparotomy: does preoperative anticoagulation matter?Int J Gynecol Cancer. 2011;21(6):1131–1134.
16.
GeertsWHBergqvistDPineoGR. Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest. 2008;133(suppl 6):381S–453S.
17.
Committee on Practice Bulletins—Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol. 2007;110(2 pt 1):429–440.
18.
AgnelliGGeorgeDJKakkarAK. Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer. New Engl J Med. 2012;366(7):601–609.
19.
FishmanAAltarasMKleinZAviramRBeythY. Low molecular weight heparin (enoxaparin) as an alternative treatment of acute deep venous thrombosis in gynecologic oncology patients. Eur J Gynaecol Oncol. 1996;17(5):365–367.
20.
DewdneySBBeenTRimelBJ. Inferior vena cava filter placement in the gynecologic oncology patient: A 15-year institutional experience. Gynecol Oncol. 2011;121(2):344–346.
21.
KearonCAklEAComerotaAJ. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e419S–e494S.
22.
MusaniMHMattaFYaekoubAYLiangJHullRDSteinPD. Venous compression for prevention of postthrombotic syndrome: a meta-analysis. Am J Med. 2010;123(8):735–740.
23.
KahnSRShrierIKearonC. Physical activity in patients with deep venous thrombosis: a systematic review. Thromb Res. 2008;122(6):763–773.
24.
PartschH. Ambulation and compression after deep vein thrombosis: dispelling myths. Semin Vasc Surg. 2005;18(3):148–152.
25.
CormierJNAskewRLMungovanKSXingYRossMIArmerJM. Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010;116(22):5138–5149.
26.
CarlsonJWKaudererJWalkerJL. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol Oncol. 2008;110(1):76–82.
ZhangSHSoodAKSoroskyJIAndersonBBullerRE. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer. 2000;89(7):1520–1525.
29.
GouldNKamelleSTillmannsT. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol. 2001;82(2):329–332.
30.
TanakaTOhkiNKojimaA. Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey. Int J Gynecol Cancer. 2007;17(2):460–464.
31.
NoldusJGraefenMHulandH. Major postoperative complications secondary to use of the Bookwalter self-retaining retractor. Urology. 2002;60(6):964–967.
32.
ChanJKManettaA. Prevention of femoral nerve injuries in gynecologic surgery. Am J Obstet Gynecol. 2002;186(1):1–7.
33.
SajidMShakirAKhatriKBaigM. Lithotomy-related neurovascular complications in the lower limbs after colorectal surgery. Colorectal Dis. 2011;13(11):1203–1213.
34.
SchneidermanBIBomzeE. Paresthesias of the lateral femoral cutaneous nerve after pelvic surgery. Am Surg. 1967;33(1):84–87.
35.
IrvinWAndersenWTaylorPRiceL. Minimizing the risk of neurologic injury in gynecologic surgery. Obstet Gynecol. 2004;103(2):374–382.
RigorBM. Pelvic cancer pain. J Surg Oncol. 2000;75(4):280–300.
38.
PortenoyRKDhingraLK.Overview of cancer pain syndromes. In: BasowDS, ed. UpToDate. Waltham, MA; 2012.
39.
DalmauJRosenfeldMR.Paraneoplastic syndromes affecting the spinal cord and dorsal root ganglia. In: BasowDS, ed. UpToDate. Waltham, MA; 2012.
40.
StevinsonCSteedHFaughtW. Physical activity in ovarian cancer survivors: associations with fatigue, sleep and psychosocial functioning. Int J Gynecol Cancer. 2009;19(1):73–78.
AlbersJWChaudhryVCavalettiGDonehowerRC.Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst Rev. 2011;(2):CD005228.
45.
RaoRDMichalakJCSloanJA. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer. 2007;110(9):2110–2118.
LoprinziCLReevesBNDakhilSR. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol. 2011;29(11):1472–1478.
48.
ReevesBNDakhilSRSloanJA. Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripherial neuropathy: North Central Cancer Treatment Group trial N08C1. Cancer. 2012.
